Whelton PK - Search Results

1

Echocardiographic identification of cardiovascular sources of emboli to guide clinical management of stroke: a cost-effectiveness analysis.

McNamara RL, Lima JA, Whelton PK, Powe NR. McNamara RL, et al. Among authors: whelton pk. Ann Intern Med. 1997 Nov 1;127(9):775-87. doi: 10.7326/0003-4819-127-9-199711010-00001. Ann Intern Med. 1997. PMID: 9382398

2

Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention.

Whelton PK, Hebert PR, Cutler J, Applegate WB, Eberlein KA, Klag MJ, Keough ME, Hamill S, Borhani NO, Hollis J, et al. Whelton PK, et al. Ann Epidemiol. 1992 May;2(3):295-310. doi: 10.1016/1047-2797(92)90062-u. Ann Epidemiol. 1992. PMID: 1342280 Clinical Trial.

3

Patient characteristics related to intensity of weight reduction care in a university medical clinic.

Brancati FL, Ford DE, Appel LJ, Klag MJ, Whelton PK. Brancati FL, et al. Among authors: whelton pk. J Gen Intern Med. 1992 Nov-Dec;7(6):609-14. doi: 10.1007/BF02599199. J Gen Intern Med. 1992. PMID: 1453244

4

Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval.

Powe NR, Griffiths RI, de Lissovoy G, Anderson GF, Watson AJ, Greer JW, Herbert RJ, Eggers PW, Milam RA, Whelton PK. Powe NR, et al. Among authors: whelton pk. JAMA. 1992 Sep 16;268(11):1434-40. JAMA. 1992. PMID: 1512912

5

Vascular reactivity in young adults and cardiovascular disease. A prospective study.

Coresh J, Klag MJ, Mead LA, Liang KY, Whelton PK. Coresh J, et al. Among authors: whelton pk. Hypertension. 1992 Feb;19(2 Suppl):II218-23. doi: 10.1161/01.hyp.19.2_suppl.ii218. Hypertension. 1992. PMID: 1735583

6

Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?

Whittle JC, Whelton PK, Seidler AJ, Klag MJ. Whittle JC, et al. Among authors: whelton pk. Arch Intern Med. 1991 Jul;151(7):1359-64. Arch Intern Med. 1991. PMID: 2064486

7

Reflections on the U.S. Preventive Services Task Force recommendations for screening for hypertension and hypercholesterolemia.

Whelton PK. Whelton PK. J Gen Intern Med. 1990 Sep-Oct;5(5 Suppl):S17-9. doi: 10.1007/BF02600834. J Gen Intern Med. 1990. PMID: 2231058

8

Effect of age on the efficacy of blood pressure treatment strategies.

Klag MJ, Whelton PK, Appel LJ. Klag MJ, et al. Among authors: whelton pk. Hypertension. 1990 Dec;16(6):700-5. doi: 10.1161/01.hyp.16.6.700. Hypertension. 1990. PMID: 2246036

9

Community cholesterol screening. Impact of labeling on participant behavior.

Gordon RL, Klag MJ, Whelton PK. Gordon RL, et al. Among authors: whelton pk. Arch Intern Med. 1990 Sep;150(9):1957-60. doi: 10.1001/archinte.150.9.1957. Arch Intern Med. 1990. PMID: 2393327

10

Magnesium and blood pressure: review of the epidemiologic and clinical trial experience.

Whelton PK, Klag MJ. Whelton PK, et al. Am J Cardiol. 1989 Apr 18;63(14):26G-30G. doi: 10.1016/0002-9149(89)90215-4. Am J Cardiol. 1989. PMID: 2650511 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results